Alkermes (ALKS) EBIT (2010 - 2026)
Alkermes (ALKS) recorded EBIT of $18.35 million in Q2 2026, down 80.3% from $92.98 million a year earlier.
Powered by 
Analysis
Alkermes (ALKS) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' EBIT came in at $117.26 million as of Jun 30, 2026, down 68.7% year-over-year; for FY2025, it was $253.96 million, down 39.6% from FY2024.
- Across earlier years, EBIT came in at $420.64 million in FY2024 (+1.6%), $414.12 million in FY2023, -$6.09 million in FY2022 and $97.75 million in FY2021.
- Quarterly EBIT has ranged from -$60.64 million in Q3 2022 to $281.27 million in Q2 2023 over the past five years.
- On a year-over-year basis, EBIT rose in two of the last seven quarters, with an average decline of 4.0%.
- Peak year-over-year performance for EBIT in the last five years was growth of 197.8% in Q4 2024, against a decline of 80.3% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -$48.28 million (Q1 2026), $58.1 million (Q4 2025) and $89.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn | 18.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.35 Mn |
| Mar 31, 2026 | -48.28 Mn |
| Dec 31, 2025 | 58.10 Mn |
| Sep 30, 2025 | 89.08 Mn |
| Jun 30, 2025 | 92.98 Mn |
| Mar 31, 2025 | 13.79 Mn |
| Dec 31, 2024 | 162.69 Mn |
| Sep 30, 2024 | 104.76 Mn |
| Jun 30, 2024 | 109.88 Mn |
| Mar 31, 2024 | 43.31 Mn |
| Dec 31, 2023 | 54.63 Mn |
| Sep 30, 2023 | 89.19 Mn |
| Jun 30, 2023 | 281.27 Mn |
| Mar 31, 2023 | -10.97 Mn |
| Dec 31, 2022 | 115.59 Mn |
| Sep 30, 2022 | -60.64 Mn |
| Jun 30, 2022 | -34.46 Mn |
| Mar 31, 2022 | -26.59 Mn |
| Dec 31, 2021 | 129.42 Mn |
| Sep 30, 2021 | -19.66 Mn |
API Access
Alkermes EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();